Abbott and Google Partner on AI-Powered Glucose Monitoring for Metabolic Health
Event summary
- Abbott partners with Google Health to integrate Lingo CGM data into Google Health app, launching a multi-year collaboration on August 11, 2026.
- The partnership aims to provide personalized metabolic insights through AI-powered health coaching in the Google Health app.
- A large-scale real-world study will combine glucose, wearable, lab, and survey data to uncover connections between daily habits and metabolic health.
- Lingo CGM is designed for non-insulin users aged 18+ to track glucose impacts from nutrition, activity, sleep, and stress.
The big picture
This partnership marks a significant step toward integrating biowearable data with consumer technology platforms to drive proactive health management. With prediabetes affecting over 115 million American adults and rising globally, the collaboration could reshape how metabolic health is monitored and managed outside clinical settings. The real-world study component positions Abbott and Google at the forefront of generating actionable insights from large-scale health data.
What we're watching
- Data Integration Challenges
- How Abbott and Google will handle the technical complexities of merging glucose data with other health metrics in a seamless user experience.
- Market Adoption
- Whether non-diabetic consumers will embrace continuous glucose monitoring as part of their daily health routines.
- Regulatory Scrutiny
- The pace at which regulators may examine the use of AI for personalized health recommendations, particularly in preventive care.
Related topics